L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

29 Mar 2024

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

L’Oreal USA, Inc. faces multiple class action complaints in US federal courts regarding its marketing of benzoyl peroxide (BPO) acne treatment drug products alleging containing benzene.

“Before being sold to the public, the [BPO] Products must be made in conformity with current good manufacturing practices and...